April 2, 2018 / 12:36 PM / 8 months ago

BRIEF-Emerald Health Therapeutics Reports Qtrly Loss Per Share C$0.04​

April 2 (Reuters) - Emerald Health Therapeutics Inc:

* EMERALD HEALTH THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* QTRLY LOSS PER SHARE C$0.04​

* HAD ABOUT $89 MILLION IN CASH AND CASH EQUIVALENTS AS AT MARCH 29, 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below